APRE 8-K 2026-11-04

Aprea Therapeutics, Inc. (APRE) 8-K dated 2026-11-04 — accession 0001104659-26-122403.

Aprea Therapeutics, Inc. (APRE) is a biotechnology company listed on US.

APRE: Therapeutics Announces Third Quarter 2026 Financial Results

This 8-K covers: Results of operations (Item 2.02), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for APRE is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The APRE SEC hub lists recent forms. The stock page is the research view.